NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization

BACKGROUND: Patients with advanced hepatocellular carcinoma (HCC) arising in nonalcoholic fatty liver disease (NAFLD) may not be suitable for systemic therapy due to metabolic syndrome-related diseases. Recent trials did not show a survival benefit of radioembolization (RE) compared to sorafenib in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Liver Cancer
Main Authors: Schotten, Clemens, Bechmann, Lars P., Manka, Paul, Theysohn, Jens, Dechêne, Alexander, El Fouly, Amr, Barbato, Francesco, Neumann, Ursula, Radünz, Sonia, Sydor, Svenja, Heider, Dominik, Venerito, Marino, Canbay, Ali, Gerken, Guido, Herrmann, Ken, Wedemeyer, Heiner, Best, Jan
Format: Artigo
Sprog:Inglês
Udgivet: S. Karger AG 2019
Fag:
Original Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6883476/
https://ncbi.nlm.nih.gov/pubmed/31799206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000501484
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker